Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- PRESENTIndependent statistical analysis of Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r): Complete Statistical AnalysisIndependent statistical analysis of Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRESERVEIndependent statistical analysis of the randomized phase 3 PRESERVE trial evaluating intravenous sodium bicarbonate versus saline and oral N-acetylcysteine versus placebo for serious patient-centered events following angiography.
- PRESERVEIndependent statistical analysis of Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRESERVEIndependent statistical analysis of Prevention of Serious Adverse Events Following Angiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01467466).
- PRESERVEIndependent statistical analysis of Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRESERVE 4Independent statistical analysis of Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRESERVE KneeIndependent statistical analysis of Subchondroplasty® Knee RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03112200).
- PRESIDEIndependent statistical analysis of A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking…
- PrESRIndependent statistical analysis of Practice Experiences for School Reintegration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05934396).
- PRESSIndependent statistical analysis of Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRESS2Independent statistical analysis of Postmarket Outcomes Study for Evaluation of the Superion™ Spacer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04563793).
- Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04582877).
- PRESSUREwire Study: Complete Statistical AnalysisIndependent statistical analysis of PRESSUREwire Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02935088).
- PRESTIGE Observational Study: Complete Statistical AnalysisIndependent statistical analysis of PRESTIGE Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00875810).
- PRESTOIndependent statistical analysis of IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice: primary endpoint results, effect estimate…
- Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010021).
- PREVACIndependent statistical analysis of PREVAC (NCT02876328), a randomized phase 2 Ebola vaccination trial evaluating antibody response through Month 12 using a stratified Cochran-Mantel-Haenszel analysis.
- PREVAILIndependent statistical analysis of A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection: primary endpoint results,…
- PREVAIL-PIndependent statistical analysis of Exercise After Clinically Significant Weight Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03685123).
- PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): Complete Statistical AnalysisIndependent statistical analysis of PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01238835).
- PrevailIIIndependent statistical analysis of Small Financial Incentives to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02737566).
- Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services: Complete Statistical AnalysisIndependent statistical analysis of Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD: Complete Statistical AnalysisIndependent statistical analysis of Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03676725).
- PREVENA-AMPIndependent statistical analysis of Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Prevenar (PCV-7) Post-Licensure Safety Study In Russia: Complete Statistical AnalysisIndependent statistical analysis of Prevenar (PCV-7) Post-Licensure Safety Study In Russia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01207583).
- PREVENTIndependent statistical analysis of Improving Patient Prioritization During Hospital-homecare Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04136951).
- PREVENTIndependent statistical analysis of Prazosin to Prevent COVID-19 (PREVENT-COVID Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365257).
- PREVENTIndependent statistical analysis of Prehabilitation of Veterans With Exercise and Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04485611).
- PREVENTIndependent statistical analysis of Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02769338).
- PREVENTIndependent statistical analysis of Reducing Emergency Diabetes Care for Older African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03466866).
- PREVENTIndependent statistical analysis of Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PREVENTIndependent statistical analysis of Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617240).
- PREVENTIndependent statistical analysis of Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PREVENT-HDA detailed statistical analysis of the phase 3 PREVENT-HD trial of rivaroxaban versus placebo in medically ill outpatients with acute symptomatic COVID-19 infection, including its time-to-event endpoints, hazard ratio, confidence interval, log-rank…
- PREVENT-HDIndependent statistical analysis of A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019…
- PREVENTERIndependent statistical analysis of PREvention of VENous ThromboEmbolism Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03006562).
- Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.: Complete Statistical AnalysisIndependent statistical analysis of Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Preventing Drug Abuse Among Sexual Minority Youth: Complete Statistical AnalysisIndependent statistical analysis of Preventing Drug Abuse Among Sexual Minority Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03954535).
- Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex: Complete Statistical AnalysisIndependent statistical analysis of Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02849457).
- Preventing Excessive Gestational Weight Gain in Obese Women: Complete Statistical AnalysisIndependent statistical analysis of Preventing Excessive Gestational Weight Gain in Obese Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01545934).
- Preventing Medication Dispensing Errors in Pharmacy Practice With Interpretable Machine Intelligence: Complete Statistical AnalysisIndependent statistical analysis of Preventing Medication Dispensing Errors in Pharmacy Practice With Interpretable Machine Intelligence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate: Complete Statistical AnalysisIndependent statistical analysis of Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665117).
- Preventing Opioid Overdose Mortality in the United States: Complete Statistical AnalysisIndependent statistical analysis of Preventing Opioid Overdose Mortality in the United States: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03924505).
- Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention: Complete Statistical AnalysisIndependent statistical analysis of Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Preventing Propofol-associated Injection Pain: Complete Statistical AnalysisIndependent statistical analysis of Preventing Propofol-associated Injection Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00864682).
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Transmission of HIV With Anti-HIV Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00074581).
- Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03207386).
- Preventing Sickle Cell Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sickle Cell Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02373241).